Delivery Order SPE2DB22D2007-SPE2DB25FJ4YM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,961.53 to AmerisourceBergen Drug Corp for Naftifine HCL 1% Cream in 60-gram units. This firm fixed-price contract, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive set-aside delivery order under DLA's pharmaceutical supply chain. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,941.77 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.92 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of May 21, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,036.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 1% CREAM 60GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Naftifine HCL 2% cream in 60-gram quantities. The $1,057.51 firm fixed-price delivery order contract has a completion date of May 28, 2025. The contract is not set-aside and is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This IDC provides a...
- The Defense Logistics Agency awarded a $1,364.53 delivery order to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. This firm fixed price, non-set-aside contract is scheduled for completion by September 5, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,319.28 firm fixed price delivery order is for the supply of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is for the delivery of Naftifine HCL 2% Cream, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,024.72 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026....
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $10,140.47 contract is for the supply of 4,565,766,159 units of Naftifine HCL 1% Cream in 60 gram tubes. There was no set-aside designation for this award. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4YMDelivery Order
The Defense Logistics Agency awarded a $6,904.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, leverages its substantial IDC with the Defense Logistics Agency to fulfill federal medical procurement needs across the Military Health System and other government healthcare entities. The company's extensive portfolio of federal contracts demonstrates its capability to deliver a wide range of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The underlying SPE2DX contract represents a critical supply mechanism enabling AmerisourceBergen to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, reflecting its established position as a key vendor in the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 9/15/25 |